- AbbVie Strikes Deal to Buy Allergan for About $63 BillionThe Wall Street Journal
- AbbVie to buy Botox-maker Allergan in a $63 billion cash-and-stock dealCNBC
- Allergan stock surges on news that Abbvie will buy Botox maker in a $63 billion dealYahoo Finance
- Allergan Agrees to $63 Billion Takeover From AbbVie in Blockbuster Pharma DealTheStreet.com
- AbbVie to buy Botox-maker Allergan in $63 billion dealReuters
- View full coverage on Google News